Psilocybin for Depression given Breakthrough Therapy status

Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA.

This latest step from the FDA, to offer psilocybin a Breakthrough Therapy designation, is a quietly extraordinary move from the federal agency, implicitly suggesting this previously stigmatized drug may have beneficial clinical uses.